Adicet Bio ACET Income Statement (2017-2026)

NASDAQ ACET
$9.47 -0.07 (-0.73%)
As of: Sep 10, 2026 · 1:16 PM EDT
Reported Financials

Adicet Bio Quarterly Income Statement

Periods 38 quarters
Latest Jun 2026

Adicet Bio reported net income of -$21.43M for the quarter ended Jun 2026. This income statement covers 38 quarters of results from Mar 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & Cost
Revenue
3.43M5.47M24.99M
Interest income
Interest Income - Total
2.92M3.00M2.73M2.07M1.68M1.40M1.17M1.52M1.34M1.17M
Interest expenses
Interest ExpensesInterest Expense
0.05M0.03M0.02M0.02M0.02M0.03M0.02M0.00M0.00M0.00M0.00M0.00M0.01M0.02M0.02M0.02M
Interest Income - Net
2.92M3.00M2.73M2.07M1.68M1.40M1.16M1.50M1.32M1.15M
Operating Items
Research & DevelopmentR&D
11.93M14.66M13.48M16.18M16.57M25.02M26.76M28.36M26.17M24.76M23.90M25.90M26.25M23.27M22.81M28.42M22.85M25.04M17.49M18.45M
Selling, General & AdministrativeSG&A
5.21M6.35M6.80M6.53M6.42M6.55M6.57M6.53M6.63M6.81M6.97M6.95M6.90M7.47M7.07M3.97M5.10M6.85M4.08M3.85M
Other Operating ExpensesOther Opex
19.46M
Operating ExpensesOpex
17.14M21.01M20.28M22.71M22.98M31.57M33.32M34.89M52.26M31.57M30.87M32.85M33.15M30.74M29.89M32.39M27.95M31.89M21.57M22.30M
Operating IncomeOp. Inc
-13.71M-15.54M4.71M-22.71M-22.98M-31.57M-33.32M-34.89M-52.26M-31.57M-30.87M-32.85M-33.15M-30.74M-29.89M-32.39M-27.95M-31.89M-21.57M-22.30M
EBIT
-13.71M-15.54M4.71M-22.71M-22.98M-31.57M-33.32M-34.89M-52.26M-31.57M-30.87M-32.85M-33.15M-30.74M-29.89M-32.39M-27.95M-31.89M-21.57M-22.30M
Non-operating items
Non Operating Interest Expenses
0.05M0.03M0.02M0.02M0.02M0.03M0.02M0.00M0.00M0.00M0.00M0.00M0.01M0.02M0.02M0.02M
Interest & Investment IncomeInt & Inv Inc
0.00M0.04M0.03M0.33M1.22M2.18M2.67M2.62M2.52M2.18M2.92M3.00M2.73M2.07M1.68M1.40M1.17M1.52M1.34M1.17M
Other Non Operating IncomeOther Non Op Inc.
-0.25M-0.29M-0.10M-0.14M-0.22M-0.46M-0.21M-0.12M-0.14M-0.10M-0.06M-0.05M-0.05M-0.05M-0.01M-0.22M-0.06M-0.13M0.01M-0.06M
Net income details
EBT
-14.00M-15.82M4.62M-22.54M-22.00M-29.88M-30.88M-32.40M-49.88M-29.49M-28.02M-29.90M-30.48M-28.73M-28.21M-31.22M-26.86M-30.52M-20.24M-21.21M
Tax ProvisionsTaxes
0.01M-0.01M-24.53M0.14M
Profit After TaxPAT
-14.01M-15.81M4.62M-22.54M-22.00M-29.88M-30.88M-32.40M-49.88M-29.49M-28.02M-29.90M-30.48M-28.73M-28.21M-31.25M-26.86M-30.52M-20.24M-21.43M
Income from Continuing OperationsIncome (Continuing)
-14.01M-15.81M4.62M-22.54M-22.00M-29.88M-30.88M-32.40M-49.88M-29.49M-28.02M-29.90M-30.48M-28.73M-28.21M-31.22M-26.86M-5.99M-20.24M-21.36M
Consolidated Net IncomeConsol Net Inc.
-14.01M-15.81M4.62M-22.54M-22.00M-29.88M-30.88M-32.40M-49.88M-29.49M-28.02M-29.90M-30.48M-28.73M-28.21M-31.22M-26.86M-5.99M-20.24M-21.36M
Income towards Parent CompanyParent Net Inc
-14.01M-15.81M4.62M-22.54M-22.00M-29.88M-30.88M-32.40M-49.88M-29.49M-28.02M-29.90M-30.48M-28.73M-28.21M-31.22M-26.86M-5.99M-20.24M-21.36M
Net Income towards Common StockholdersNet Income
-14.01M-15.81M4.62M-22.54M-22.00M-29.88M-30.88M-32.40M-49.88M-29.49M-28.02M-29.90M-30.48M-28.73M-28.21M-31.22M-26.86M-30.52M-20.24M-21.36M
Additional items
EPS (Basic)
-7.03-8.171.86-9.00-8.45-11.64-11.50-12.07-18.57-10.96-5.67-5.28-5.37-5.23-4.96-5.48-4.72-4.43-1.88-1.99
EPS (Diluted)
-7.03-8.171.61-9.00-8.45-11.64-11.50-12.07-18.57-10.96-5.67-5.28-5.37-5.23-4.96-5.48-4.72-4.43-1.88-1.99
Shares Outstanding
1.99M1.93M2.49M2.50M2.60M2.57M2.68M2.68M2.69M2.69M4.94M5.66M5.68M5.49M5.69M5.69M5.69M6.89M10.74M10.75M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
1.99M1.93M2.87M2.50M2.60M2.57M2.68M2.68M2.69M2.69M4.94M5.66M5.68M5.49M5.69M5.69M5.69M6.89M10.74M10.75M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
2.00M1.93M2.50M2.50M2.67M2.68M2.68M2.69M2.69M2.70M5.14M5.15M5.15M5.16M5.17M5.20M5.20M6.89M9.60M9.36M
EBITDA
-13.71M-15.54M4.71M-22.71M-22.98M-31.57M-33.32M-34.89M-52.26M-31.57M-30.87M-32.85M-33.15M-30.74M-29.89M-32.39M-27.95M-31.89M-21.57M-22.30M